13,287
Total Claims
$2.1M
Drug Cost
1,441
Beneficiaries
$1,443
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+37%
Cost per patient vs peers
$1,443 vs $1,054 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 11,695 claims · $283K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 695 | $767K |
| Rivaroxaban | 277 | $347K |
| Sacubitril/Valsartan | 163 | $201K |
| Empagliflozin | 48 | $73K |
| Dronedarone Hcl | 47 | $69K |
| Dapagliflozin Propanediol | 40 | $51K |
| Ticagrelor | 29 | $28K |
| Metoprolol Succinate | 1,324 | $27K |
| Icosapent Ethyl | 24 | $20K |
| Atorvastatin Calcium | 1,378 | $19K |
| Evolocumab | 17 | $19K |
| Telmisartan/Hydrochlorothiazid | 87 | $11K |
| Rosuvastatin Calcium | 22 | $11K |
| Losartan Potassium | 749 | $10K |
| Pravastatin Sodium | 541 | $9,874 |
Prescribing Profile
81
Unique Drugs
$1.4M
Patient Profile
77
Avg Age
48%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About